Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Nuvaxovid JN.1 dispersion for injection, COVID-19 Vaccine (recombinant, adjuvanted) {equilateral_black_triangle}

Active Ingredient:
SARS-CoV-2 recombinant spike protein
Company:  
Novavax, Inc See contact details
ATC code: 
J07BN04
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Patient Leaflet (PIL) HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 15 Nov 2024

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Novavax, Inc
Company image
Address
21 Firstfield Road, Gaithersburg, Maryland, 20878, USA
Telephone
+1 240-268-2000
Fax
+1 240-268-2100
Medical Information Direct Line
+44 020 3514 1838
Medical Information Website
novavaxmedinfo.com
Customer Care direct line
+44 020 3514 1838
WWW
www.Novavax.com
WWW
www.novavaxcovidvaccine.com